Downregulation of miR-137-5p in Serum of Alzheimer's Disease Patients
Serum analysis reveals a significant downregulation of miR-137-5p in patients diagnosed with Alzheimer's disease. This finding suggests a potential role of miR-137-5p in the pathogenesis of Alzheimer's disease and its potential as a diagnostic or therapeutic biomarker.
原文地址: http://www.cveoy.top/t/topic/fv1F 著作权归作者所有。请勿转载和采集!